Material Safety Data Sheet
OSHA’S Hazard
Communications CFR 1910.1200
1. PRODUCT AND COMPANY IDENTIFICATION
*PRIDE BRAKE FLUID
Processor: Davison Oil Company, Inc. Information: 334-633-4444
________________________________________________________________________
2. INGREDIENTS
Proprietary mixture of glycol ethers, polyglycols, glycols, oxidation inhibitors and corrosion.
________________________________________________________________________
3. PHYSICAL INFORMATION
Boiling Point: 430°F, 2210 minimum Specific Gravity: 1.03
VAP Press: Low Appearance: Amber Liquid
VAP Density: Not determined Odor: Mild Odor
________________________________________________________________________
4. FIRE AND EXPLOSION HAZARD INFORMATION
Flash Point: 272°, 1330
Method Used: PMCC
Flash Point used by COC: 280°F, 1380
Flammable Limits: N/A
Extinguishing Media: Water, fog, alcohol-resistant foam, CO2, dry chemical.
Fire and Explosion Hazards: Product will burn. Burning produces carbon dioxide, carbon monoxide and water.
Fire-Fighting Equipment: Water Positive-pressure, self contained breathing apparatus.
5. REACTIVITY INFORMATION
Stability: Stable under normal storage.
Incompatibility: Strong oxidizing materials.
Hazardous Polymerization: Will not occur.
________________________________________________________________________
6. ENVIRONMENTAL AND DISPOSAL INFORMATION
Action to take for spills/leaks: Do not allow to contaminate ground water. Soak up with suitable absorbent material and scoop into drums.
Disposal method: Burn in an approved incinerator in accordance with the local, state, and federal requirements.
________________________________________________________________________
7. HEALTH HAZARD INFORMATION
Eye: May cause moderate eye irritation. May cause moderate corneal injury.
Skin Contact: Prolonged or repeated exposure may cause skin irritation. May cause more severe response if skin is abraded (scratched or cut.)
Skin Absorption: A single prolonged exposure is not likely to result in the material being absorbed through the skin in harmful amounts. The dermal LD50 has not been determined. Prolonged or repeated skin contact with large amounts of some of the ingredients of this formulation may cause drowsiness.
Ingestion: Single dose oral toxicity is low. The oral LD50 for rats is believed to be >2000 mg/kg. Amounts ingested incidental to industrial handling are not likely to cause injury; however, ingestion of larger amounts may cause injury.
Inhalation: Vapors are minimal due to physical properties; a single exposure is not likely to be hazardous.
Systemic & Other Effects: No relevant information available on the major components. The minor components in this formulation when tested separately (Usually by ingestion) have caused kidney, liver gastrointestinal, testicular and central nervous system effects; bladder stones; nausea vomiting. Two minor components have been tested for carcinogenicity and pose no carcinogenic risk to man. Minor components, when tested separately, have shown little or no birth defect risk for humans although fetal toxicity has occurred in animal studies and one component caused birth defects in animals following ingestion of large doses. Some minor components, when tested separately, have been shown not to interfere with reproduction, although one of these minor components was slightly toxic to the offspring of treated female rats. Of the minor components tested for mutagenicity, only one has produced some positive results along with negative in vitro (test tube) tests.
8. FIRST AID
EYES: IRRIGATE WITH FLOWING WATER IMMEDIATELY AND CONTINUOUSLY FOR 15 MINUTES. CONSULT MEDICAL PERSONELL.
SKIN: WASH OFF IN FLOWING WATER OR SHOWER.
INGESTION: INDUCE VOMITING IF LARGE AMOUNTS ARE INGESTED.
CONSULT MEDICAL PERSONNEL.
INHALATION: REMOVE TO FRESH AIR IF EFFECTS OCCUR. CONSULT A PHYSICIAN.
NOTE TO PHYSICIAN: NON-SPECIFIC ANTIDOTE. SUPPORTIVE CARE.
TREATMENTS BASED ON JUDGEMENT OF THE PHYSICIAN IN RESPONSE TO REACTIONS OF THE
PATIENT.
_____________________________________________________________________
9. HANDLING PRECAUTIONS
Exposure Guideline: There are no guidelines established for the
principle components. One minor component has an AIHA WEEL of 50ppm; another
has an ACGIH TLV of 100 ppm skin.
Ventilation: Good general ventilation should be sufficient for best conditions.
Respiratory Protection: For brief contact, no precaution other than clean body-covering clothing should be needed. If hands are cut or scratched, use impervious gloves even for brief exposures. Use impervious gloves when prolonged for frequently repeated contact could occur.
_____________________________________________________________________
10. ADDITIONAL INFORMATION
Special precautions to be taken in handling storage: Practice reasonable care and personal cleanliness.
Notice: The information herein is presented in good faith and believed to be accurate as of the effective date shown above. However, no warranty, express or implied, is given. Regulatory requirements are subject to change and may differ from one location to another; it is the buyer’s responsibility to ensure that its activities comply with federal, state or provincial, and local laws.